StockData
Oramed Pharmaceuticals Inc. logo

Oramed Pharmaceuticals Inc. (ORMP) income statement

ORMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/30
$3.89+0.02 (+0.52%)

Close on Nov 18, 2026Market cap $161.81MP/E 0.9Yield 6.43%

Oramed Pharmaceuticals Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin
0.7%
Operating margin
-726.2%
Net margin
8743.5%
Return on equity, FY2025
37.0%

Financial strength

Current ratio
4.98
Debt to equity
–
Debt to assets
–
Cash to current liabilities
142.1%

Valuation

P/E ratio
0.9
Price to sales
–
Price to book
–
Dividend yield
6.43%

See a number that looks wrong?